For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
‘No more reviews’ says Shane Reti: But health minister tight-lipped over funding
+News
In print
‘No more reviews’ says Shane Reti: But health minister tight-lipped over funding
Wednesday 28 February 2024, 10:00 AM

Will a tight Budget 2024 delay capitation funding and increased support for GPs? [Image: Simon Maude NZD]
Health minister Shane Reti says he’s not interested in any more primary care reviews, so what’s happened to the ‘roadmap’, and what will he do to address the problems facing the sector? Stephen Forbes reports
Cabinet paper - Achieving Pae Ora Through Primary Care, Sapere report on future approach to capitation funding
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.